Featured Research

from universities, journals, and other organizations

Allergies? Some pollens are much more aggressive than others

Date:
May 21, 2012
Source:
Technische Universitaet Muenchen
Summary:
There are pollens -- and then there are pollens, as scientists from across Europe discovered while investigating the allergic potential of pollens from the three main triggers of hay fever in Europe: birch, grass and olive. Different people can have very different allergic reactions to a particular type of pollen.

Birch pollen.
Credit: Copyright TU Muenchen

There are pollens -- and there are pollens, as scientists from across Europe discovered while investigating the allergic potential of pollens from the three main triggers of hay fever in Europe: birch, grass and olive. Different people can have very different allergic reactions to a particular type of pollen, however, and as the Hialine study researchers have now found, the allergenicity of the pollens also varies. Depending on the time of year and region, the pollens produce different quantities of protein compounds. These are ultimately responsible for the allergic immune reaction.

From Finland to Italy and from Spain to Lithuania, thirteen research institutes from eleven European countries took part in the three-year Hialine study. The coordinator was Professor Dr Jeroen Buters of TUM's Chair of Molecular Allergology and the Center of Allergy & Environment (ZAUM). The mission was to study the three main causes of hay fever in Europe, i.e. the pollen (germ cells) of birch trees, grass and olive plants. Sufferers develop allergic symptoms when they come in contact with the allergen to which they are sensitized. Up until now, the only way to ascertain how seriously patients will be affected is by measuring the airborne pollen concentration.

However, this method gives very little indication of how aggressive the pollens are. Depending on their level of maturation, the pollens of a particular plant species not only produce different allergens, but the number of allergenic proteins present also varies. The researchers were therefore keen to find the connection between pollen count and amount of allergens released. They focused on the main allergen found in each of the three plant species: Bet v 1 (birch), Phl p 5 (grass) and Ole e 1 (olive). They discovered that the pollen count aligns closely with the number of allergens released.

However, some striking differences were noticed on certain days and at particular measuring stations, as study director Jeroen Buters explains: "The allergic potential varied by a factor of 10. In other words up to ten times more allergens were released on the 'intense' days than at other times." On comparison of the levels at the various measuring locations in Europe, the researchers noticed the greatest fluctuations in the grass pollens. With seven times the number of Phl p 5 allergens, the grass pollens in France were significantly more aggressive than those in Portugal. The birch pollens, by contrast, showed smaller variations. Interestingly, geographical distance seems to have played only a minor role: At two olive measuring stations located only 400 kilometers apart, the scientists observed that the allergen level was four times greater at one of the locations.

The weather was influential too, as Buters relates: "At the measuring station in Portugal, we found a high concentration of the Ole e 1 allergen, even though there was hardly any airborne pollen in Portugal at that time. We did some meteorological calculations and concluded that the allergen had blown in from Spain, where pollens have a significantly higher allergic potential."

According to the study's findings, measuring the allergens would be more useful to allergy sufferers than forecasting the pollen count. "By combining allergen measurements, airborne pollen forecasts and weather data, we can significantly improve the allergy models used to date." Buters also sees new hope for the treatment of allergy sufferers: "The only true therapy for an allergy is hyposensitization, i.e. the sufferer must become accustomed to the allergen over a long period of time. So instead of pollen extracts, doctors could vaccinate patients with allergenic proteins -- the real triggers of an allergy. This would be much more effective in targeting the cause of the problem."


Story Source:

The above story is based on materials provided by Technische Universitaet Muenchen. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jeroen T.M. Buters, Michel Thibaudon, Matt Smith, Roy Kennedy, Auli Rantio-Lehtimδki, Roberto Albertini, Gerald Reese, Bernhard Weber, Carmen Galan, Rui Brandao, Celia M. Antunes, Siegfried Jδger, Uwe Berger, Sevcan Celenk, Łukasz Grewling, Bogdan Jackowiak, Ingrida Sauliene, Ingrid Weichenmeier, Gudrun Pusch, Hakan Sarioglu, Marius Ueffing, Heidrun Behrendt, Marje Prank, Mikhail Sofiev, Lorenzo Cecchi. Release of Bet v 1 from birch pollen from 5 European countries. Results from the HIALINE study. Atmospheric Environment, 2012; 55: 496 DOI: 10.1016/j.atmosenv.2012.01.054

Cite This Page:

Technische Universitaet Muenchen. "Allergies? Some pollens are much more aggressive than others." ScienceDaily. ScienceDaily, 21 May 2012. <www.sciencedaily.com/releases/2012/05/120521115520.htm>.
Technische Universitaet Muenchen. (2012, May 21). Allergies? Some pollens are much more aggressive than others. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/05/120521115520.htm
Technische Universitaet Muenchen. "Allergies? Some pollens are much more aggressive than others." ScienceDaily. www.sciencedaily.com/releases/2012/05/120521115520.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins